Large Language Models are AI systems trained on very large amounts of data, like internet text, to understand and create human-like language. In healthcare, LLMs can do tasks like answering front-office phone calls, talking to patients, or helping doctors by summarizing data and suggesting treatment options.
When these tools help with medical decisions or patient communication, the U.S. Food and Drug Administration (FDA) may consider them software as a medical device (SaMD). This means they need to follow rules to make sure they are safe and work well in clinical use.
Unlike regular medical devices such as tools or drugs, software models change quickly. They learn and get updated often. This makes it hard for the FDA, because their current rules are often too slow or strict for the fast changes in AI. This creates challenges to keep the models safe, private, and effective before using them in healthcare.
One big problem with regulating LLMs is that there are no special rules for software medical devices that keep learning and changing. The FDA’s rules were mostly made for physical devices or software that does not change. They don’t handle constant updates and real-world changes well.
AI changes fast, so rules need to be flexible. They should allow ongoing checks and real-time proof that the AI works right after it is used. Current rules don’t cover some risks like:
Because AI grows faster than regulations change, the rules must become adaptable. This helps keep AI fair and safe even when models update quickly.
Besides following rules, there are ethical issues when using LLMs in healthcare. A 2023 paper from Harvard Medical School and Massachusetts General Hospital points out two important ethics: empathy and equity.
Human empathy is the ability to feel and understand others’ emotions. This is important in good patient care. LLMs can copy sympathy in language but cannot truly feel empathy. Artificial empathy is not the same as human connection. If we rely too much on AI, we risk losing this key part of care. Patients can tell the difference and may trust less when only AI is involved.
Experts say artificial empathy should help, not replace, human empathy. For example, AI phone systems like Simbo AI can handle simple calls and reduce staff workload. But doctors and nurses still need to talk with patients directly to support their dignity and health.
LLMs learn from data taken from many online places. These data often have existing biases in society. Some studies found that AI models link negative words more with names common in African American groups. This can increase unfair differences in healthcare if not controlled.
To promote fairness:
Without strong protections, using LLMs may unintentionally harm vulnerable groups and deepen inequality. Clear processes with doctor involvement help ensure fair care for all patients.
People agree that a strong governance system is needed to guide AI use in healthcare. Experts like Massimo Esposito and others suggest building rules that balance new technology with patient safety and ethics.
Important parts of this system include:
Groups like the World Economic Forum and Coalition for Health AI have offered plans that call for diverse training data, regular bias checks, and doctor-led AI reviews. These plans want to make AI a helpful part of care without hurting ethics or safety.
Medical office managers and IT teams need to know how LLMs change daily work. Simbo AI is an example that offers AI-based front-office phone automation made for healthcare.
Phone calls take up a lot of time in clinics. LLMs let automated systems do routine jobs like setting appointments, answering patient questions, sorting calls, and gathering patient information before visits.
This can:
Besides office tasks, LLMs help doctors by summarizing patient histories, managing electronic health records, and checking current treatment guidelines. These help save time and improve decision-making.
Still, it is important that:
Using AI tools like Simbo AI’s phone service can make offices run smoother while keeping human contact strong for patient trust and satisfaction.
Research and experts agree that doctors must lead the way in creating, using, and checking LLMs in healthcare.
Doctors and clinical leaders have the knowledge to:
This doctor-led approach makes sure LLMs work as helpers, not replacements, and supports fair results by balancing technology with personal care.
LLMs change as they learn new information or get updated with fresh data. So, bias that was not noticed before may appear later and affect care.
Ongoing bias checks need:
Without constant watch, the risk of worsening inequality grows. Rules and healthcare groups must create policies that make AI fair and responsible during its entire use.
Right now, the FDA reviews AI software before it is used, but this method does not fit well with AI that changes fast. Developers must show proof of safety and effectiveness, but updating AI often needs new reviews that slow progress.
Experts say that:
Bringing together AI researchers, doctors, policy makers, and regulators is key to building systems that support responsible, fair AI use in U.S. healthcare.
Medical office managers, practice owners, and IT teams face challenges when adding LLMs to their work. They should know that:
By knowing these points, healthcare leaders can plan well and make sure AI helps improve fair, effective, and caring treatment for patients.
Using large language models safely in U.S. healthcare depends on strong rules, ethical practices, and careful use. Healthcare managers and IT professionals who work closely with doctors and AI makers to follow flexible guidelines will manage this technology best to benefit all patients with safety, fairness, and human care.
The key ethical considerations include empathy and equity. Empathy involves maintaining genuine human connection in patient care, as artificial empathy from LLMs cannot replace real human empathy. Equity focuses on addressing inherent biases in LLMs’ training data to prevent amplification of existing healthcare disparities.
LLMs can use empathetic language but lack true empathy felt from human physicians. Artificial empathy should complement, not replace, human empathy to preserve the therapeutic alliance and mitigate patient isolation, particularly given the public health importance of human connection in care.
LLMs are trained on data from the internet containing racial, gender, and age biases which can perpetuate inequities. Equitable integration requires addressing these biases through evaluation, mitigation strategies, and regulatory oversight to ensure improved outcomes for all patient demographics.
Biased LLMs risk reinforcing systemic inequities by associating negative stereotypes with certain demographic groups, potentially leading to unfair, harmful treatment recommendations or patient communications, thus worsening health disparities if not carefully monitored and regulated.
Clinicians must lead LLM deployment to ensure holistic, equitable, and empathetic care. Their involvement is essential for recognizing and mitigating model biases, integrating LLMs as tools rather than replacements, and maintaining direct empathetic interactions with patients.
Measures include regulatory development for continuous technology evaluation, professional societies updating LLM use guidelines, funding projects targeting health equity improvements via LLMs, industry collaborations with healthcare professionals, and prioritization of equity-focused research publications.
LLMs should augment physician-led care by supporting administrative and informational tasks, thereby freeing physicians to engage more in empathetic dialogue with patients. This preserves human connection critical for patient dignity and therapeutic relationships.
There is currently no robust FDA pathway for software as a medical device, complicating regulation. Rapid LLM development requires expeditious, adaptive guidelines focusing on continuous evaluation, bias assessment, and ensuring patient safety and fairness.
Bias can evolve or become amplified as LLMs are applied in new contexts, potentially causing harm. Continuous bias assessment allows for timely mitigation, ensuring models provide equitable care and do not perpetuate structural inequities.
A physician-led, justice-oriented innovation framework is advised. It emphasizes continuous bias evaluation, human oversight, transparency regarding AI use, and collaboration among clinicians, ethicists, AI researchers, and patients to ensure LLMs enhance equitable and empathetic care.
Simbo is using AI agents to automate all phone related workflows. Connect now to know more.
Schedule AI Agents Demo Now© Since 2019, Simbo AI.
